Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2004
05/27/2004US20040102436 Heterocyclic compound derivatives and medicines
05/27/2004US20040102432 Asthma, rhinitis therapy
05/27/2004US20040102428 Chemokine receptor binding heterocyclic compounds
05/27/2004US20040102423 Spironolactone and angiotensin II antagonist combination therapy for treatment of congestive heart failure
05/27/2004DE10252969A1 New 3-aminomethylene-indoline-2-(thi)one derivatives, are kinase inhibitors useful for treating proliferative diseases e.g. tumors, rheumatoid arthritis, neovascular glaucoma and arteriosclerosis
05/27/2004CA2765093A1 Bicyclic-substituted amines as histamine-3 receptor ligands
05/27/2004CA2505819A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
05/27/2004CA2505361A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
05/27/2004CA2505127A1 Ophthalmic compositions for treating ocular hypertension
05/26/2004EP1422553A1 Improved base precursors for use in a photothermographic element
05/26/2004EP1422219A1 Cyclic amine compound
05/26/2004EP1422218A1 Antiviral agent
05/26/2004EP1421105A1 Anti-cancer cyclopenta[g]quinazoline compounds
05/26/2004EP1421078A1 Beta-3 adrenergic agonists
05/26/2004EP1421077A2 Novel pyrazole analogs acting on cannabinoid receptors
05/26/2004EP1421070A1 New piperidinyl derivates as modulators of chemokine receptor activity
05/26/2004EP1421056A1 (alpha)-haloenamine reagents
05/26/2004EP1420784A1 Compounds effecting glucokinase
05/26/2004EP1117652B1 Tan-1057 derivatives
05/26/2004EP1027332B1 Novel lactam metalloprotease inhibitors
05/26/2004CN1500087A 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors
05/26/2004CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases
05/26/2004CN1500081A Thiohydantonins and use thereof for treating diabetes
05/26/2004CN1499972A Imidazolyl derivatives as corticotropin releasing factor inhibitors
05/26/2004CN1499970A Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods
05/26/2004CN1498885A Synthesizing 3-acylamino pyrazole
05/26/2004CN1151149C Substituted bisindolyl maleimides for inhibition of cell proliferation
05/26/2004CN1151148C Farnesy transferase inhibitors having pyrrole structure and process for preparation thereof
05/26/2004CN1151147C Indole derivatives as 5-HT receptor antagonist
05/26/2004CN1151136C Fused pyridazine compound
05/26/2004CN1151133C Anthranilic acid amides and use thereof as medicaments
05/26/2004CN1151127C Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
05/25/2004US6740760 Such as 1-((s)-3-mercapto-2-methyl-propionyl)-(r)-pyrrol-idine-2-carboxylic acid for treating diseases associated with amyloidosis (alzheimer's disease, diabetes, and familial amyloid polyneuropathy)
05/25/2004US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury.
05/25/2004US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma
05/25/2004US6740654 Inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders, or disorders involving the inappropriate growth or migration of cells.
05/25/2004US6740649 Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE)
05/25/2004CA2302058C A process for preparing 5-methoxy-4-methyl-2,4-dihydro-3h-1,2,4-triazol-3-one
05/21/2004WO2004041816A1 Azacyclic compounds as orexin receptor antagonist
05/21/2004WO2004041814A1 Heteroaryl-pyramidine derivatives as jak inhibitors
05/21/2004WO2004041810A1 Compounds useful as inhibitors of jak and other protein kinases
05/21/2004WO2004041809A2 Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands
05/21/2004WO2004041808A1 4-imidazol-1-ylmethyl-pyrimidine derivatives_as ligands for gabaa receptors
05/21/2004WO2004041807A1 Novel compounds
05/21/2004WO2004041795A1 Novel inhibitors of dipeptidyl peptidase iv
05/21/2004WO2004041788A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
05/21/2004WO2004041782A1 Indoles useful in the treatment of androgen-receptor related diseases
05/21/2004WO2004041273A1 DERIVATIVES OF [6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3-SULFONYL]-PYRROLIDINE-2-CARBOXYLIC ACID AMIDE AS ANTI-INFLAMMATORY AGENTS
05/21/2004WO2004041209A2 Transcription factor modulating compounds and methods of use thereof
05/21/2004WO2004005406A3 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices
05/21/2004WO2004004629A3 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
05/21/2004WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists
05/21/2004CA2507406A1 Compounds useful as inhibitors of jak and other protein kinases
05/21/2004CA2506773A1 Heteroaryl-pyramidine derivatives as jak inhibitors
05/21/2004CA2504131A1 Derivatives of [6,7-dihydro-5h-imidazo[1,2-alpha]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide as anti-inflammatory agents
05/21/2004CA2495708A1 4-imidazol-1-ylmethyl-pyrimidine derivatives as ligands for gabaa receptors
05/21/2004CA2484936A1 Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands
05/20/2004US20040097734 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
05/20/2004US20040097730 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors
05/20/2004US20040097725 Charge transport compositions and electronic devices made with such compositions
05/20/2004US20040097574 For therapy of inflammatory, allergic, or proliferative processes
05/20/2004US20040097571 Imidazole compounds and their use as adenosine deaminase inhibitors
05/20/2004US20040097570 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
05/20/2004US20040097568 Crystalline form of losartan potassium
05/20/2004US20040097545 Quinolinone derivatives
05/20/2004US20040097532 3-Substituted oxindole beta 3 agonists
05/20/2004US20040097531 For therapy of inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, neurodegenerative disease, allergy, reperfusion/ischemia in stroke, heart attack, hypoxia
05/20/2004US20040097504 Compositions useful as inhibitors of jak and other protein kinases
05/20/2004US20040097503 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof
05/20/2004US20040097501 Triazole compounds useful as protein kinase inhibitors
05/20/2004US20040097497 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
05/20/2004US20040097496 Novel thiazine derivatives
05/20/2004US20040097491 For use as antithrombotic agents
05/20/2004US20040097471 For therapy and prophylaxis of influenza infection
05/20/2004US20040097438 Fused-ring compounds and use thereof as drugs
05/20/2004US20040097376 Controlling weeds
05/20/2004US20040096787 Color photography
05/20/2004US20040093676 Chromatic direct dyes
05/19/2004EP1420016A1 Crystal and process for producing the same
05/19/2004EP1420015A1 Imidazolyl derivatives
05/19/2004EP1419152A1 Hiv inhibiting pyrimidines derivatives
05/19/2004EP1419151A1 Chrystals including a malic acid salt of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indole-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof
05/19/2004EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
05/19/2004EP1418906A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments
05/19/2004EP1273575B1 Diazepane derivatives or salts thereof
05/19/2004EP1259505B1 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
05/19/2004EP1086097B1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
05/19/2004EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors
05/19/2004EP1020453B1 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both
05/19/2004EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
05/19/2004EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4
05/19/2004EP0874629B1 ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS
05/19/2004EP0722936B1 Fused pyridazine compound
05/19/2004EP0717736B1 Phosphorus derivatives to treat aids
05/19/2004DE10251019A1 New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer
05/19/2004DE10250708A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
05/19/2004CN1498216A Noval crystal and solvate forms of ondansetron hydrochloride and process for their preparation
05/19/2004CN1498212A New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors
05/19/2004CN1496982A Imidazoline compound, its preparation method and drug composition containing them
05/19/2004CN1496981A Cycloamine derivative and its use as medicine